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Influenza viruses cause disease in millions of individuals worldwide per year through 
seasonal epidemics and, less frequently, through avian influenza outbreaks and pandemics. 
Generally, women of reproductive ages experience greater morbidity and mortality when 
compared to their male counterparts during these outbreaks. Although sex and gender have 
been considered in epidemiological, clinical, and animal studies of infection and vaccination, 
no studies have considered whether the donor sex of cell cultures affects the response to 
infection with influenza A virus. To better understand and characterize the sex differences 
in response to influenza A virus infection, we infected primary, differentiated human nasal 
epithelial cell (hNEC) cultures from male and female donors with recombinant influenza 
A/Udorn/307/72 H3N2 virus. We tested the hypothesis that hNECs from male and female 
donors would replicate virus to the same titer as well as have a different innate immune 
response to infection.  Following infection, viral infection kinetics and titers were similar in 
hNEC cultures from male and female donors.  hNEC cultures from female donors produced 
more IFN-λ than their male counterparts while hNEC cultures from male donors produced 
higher concentration of several chemokines. Cultures derived from males also displayed 
greater antiviral transcriptional activity. In summary, these data suggest that hNECs from 
male donors have a greater innate immune response to infection than females, but this 
does not impact the ability to control infection. These data provide novel insights into how 
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Influenza Virus Biology 
Influenza is caused by members of the Orthomyxoviridae family of viruses: 
influenza A, B, and C. Influenza A viruses (IAV) are the most common cause of influenza 
in humans and induce the most severe symptoms (WHO, 2015). The IAV genome is 
comprised of eight, negative-sense, RNA segments that encode for 11 proteins, 
including matrix proteins (M) 1 and 2, nonstructural protein (NS) 1 and polymerase basic 
(PB) 1, which are important for structure, function, and dissemination of the virus. The 
surface proteins hemagglutinin (HA) and neuraminidase (NA) are the immunodominate 
antigens; the combination of HA and NA determines the strain of influenza (Lagace-
Wiens et al., 2010; Gorman et al., 1991). Selective pressure from the host immune 
system drive the evolution of the surface glycoproteins of the virus enabling the virus to 
infect individuals with new strains despite previous influenza infections (Gorman et al., 
1991). Single point mutations in the RNA amino acid sequence of the virus result in 
antigenic drift (Jagger et al., 2012) while coinfection of a single host with two different 
viruses can result in genetic reassortment of the virus genome, termed antigenic shift 
(Gorbach et al., 2014). Both antigenic shift and drift are responsible for the eighteen HA 
and eleven NA glycoproteins that have been identified of which 3 HA (H1, H2, H3) and 
two NA (N1 and N2) are responsible for human pandemics (Gorbach et al., 2014). These 
genetic reassortments of the virus have the ability to produce novel influenza viruses 
capable of causing the next epidemic or pandemic in a naïve population.  
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The hemagglutinin of IAVs is a homotrimer that forms spikes on the surface of 
the virion, allowing it to bind to the sialic acid receptors on the surface of the host cell 
membrane (Nayak et al., 2009). These sialic acid receptors, (2,3) and (2,6), confer 
species specificity with human IAVs generally recognizing the (2,6) formation while 
avian IAVs preferentially utilize (2,3). Swine IAVs can form linkages with both (2,3) 
and (2,6) receptors making it an ideal vessel for viral recombination (Samji, 2009). 
During viral release from an infected cell, NA is responsible for cleaving the IAV bond 
with the sialic acid receptor, aiding in the release of viral progeny from the cell (Nayak et 
al., 2009). The inherent virulence of IAV is a major determinant of the severity of illness 
associated with infection (WHO, 2015).   
Influenza A viruses undergo several steps after binding to its preferred sialic acid 
receptor in order to transfer its genetic material and ultimately replicate. After the virus 
enters the cell via endocytosis, the vesicle it is contained within fuses with a host 
endosome. Once the viral and endosome membranes fuse, the drop in pH allows for 
conformation changes of the HA protein; this then disrupts interact between the viral 
ribonucleoproteins (vRNPs) and the M1 and M2 proteins which allows the vRNPs to 
enter the cytoplasm (Yoshimura et al., 1982). The vRNPs then travel to the nucleus 
where they are taken up and the transcriptase contained within the vRNPs transcribes 
the viral RNA into mRNA, which can then be used to synthesize new viral proteins. The 
new virions are packaged and then bud from the cell surface from which they initially 
attached. Viral NA cleaves the sialic acid receptor to release the new virion back into the 




Infection of Epithelial Cells by Influenza Viruses 
In humans, seasonal strains of IAV infect ciliated epithelial cells in the nasal 
cavity, trachea, and bronchi,--components of the upper and lower respiratory tracts 
(Eccles, 2005). Avian strains of IAV, such as H5N1 and H7N2, typically infect only the 
lower respiratory tract, such as the alveolar type 2 pneumocytes and club cells of the 
bronchi (Short et al., 2014). These differences in infection sites impact the severity of 
disease. Uncomplicated cases of seasonal influenza are generally associated with 
infection limited to the upper respiratory tract, with nonspecific symptoms, including 
cough, sore throat, fever, and myalgia, arising from inflammation of the respiratory 
system. In the lower respiratory tract, the virus can damage these very sensitive tissues 
that are necessary for gas exchange, including type 1 and 2 pneumocytes, leading to 
respiratory difficulties and more severe disease (Short et al., 2014). Complicated cases 
of seasonal influenza most often occur in individuals with compromised immune 
systems or those suffering from other co-morbidities, such as chronic obstructive 
pulmonary disease (COPD) (WHO, 2015). However, healthy individuals can present with 
similar complications from IAV infections, especially when infected with pandemic or 
epidemic strains of the virus (Short et al., 2014).  
Data on the interaction of IAVs with mouse and human epithelial cells 
demonstrate that the presence of sialic acid receptors on epithelial cells determines 
susceptibility to IAV infection.  A study of cell tropism and cell susceptibility to IAV 
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infection demonstrated differences in virus-specific receptor location in humans as 
compared with mice.  Ciliated mouse tracheal epithelial cells (mTECs) and human 
tracheal epithelial cells (hTECs) were found to both express 2,3-sialic acid receptors 
making them both susceptible to infection with mouse adapted recombinant influenza 
A/WSN/33 H1N1  (rWSN) (Yan et al., 2016). In contrast, infection with 
A/California/7/2009 H1N1 (2009 H1N1) productively infected both ciliated and 
nonciliated hTECs expressing the 2,6-sialic acid receptor. Importantly, mTECS lack the 
2,6-sialic acid receptor and, therefore, 2009 H1N1 could not infect mTECs (Yan et al., 
2016).   
To further examine the ability of human strains to infect cells from mice and 
humans, the human seasonal lab-adapted IAV strain, A/Udorn/72 H3N2 rUdorn H3N2 
was introduced into mTEC and hTEC culture. The H3N2 rUdorn virus was able to infect 
both ciliated and nonciliated cells in the hTECs using both 2,6 and 2,3 receptors, 
whereas rUdorn could only infected  ciliated cells expressing the 2,3 receptor in the 
mTECs (Yan et al., 2016). The results of this study demonstrated that the 2,3-type 
receptor is present in both human and mouse primary tracheal cells. It also showed that 
the presence of cilia was necessary for infectivity of certain strains of IAV such as rWSN. 
It also demonstrated species-specific differences in receptor positive cells; mTECs lack 
2,6-type receptors and thus are not susceptible to strains of influenza that can only 
utilize that receptor (Yan et al., 2016).  Other studies have been conducted that 
examined receptor type in hNECs from several individuals the results of which again 
demonstrated viral preference for certain sialic receptor types (Ibricevic et al., 2006). 
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Ultimately, it is the receptor type present in the susceptible cells as well as the sialic acid 
residue preference of the virus that determines how efficiently and effectively a virus 
can infect a host.  
 
Innate Immune Responses to Influenza Viruses 
In humans, once IAV invades the epithelial tissues in the respiratory tract the 
immune cells recognize the pathogen and begin to respond. Within the mucosal surface, 
nonspecific proteins try to bind the influenza particle and clear it via the mucocilary 
apparatus (Mandell et al., 2014). If this is ineffective, then the virus enters the host cell 
triggering the innate immune response. When IAV first encounters respiratory epithelial 
cells and penetrates them to begin replication, pattern recognition receptors (PRRs), 
including the toll-like receptors (TLR) such as TLR3, 7, 8 and 9, within the epithelial 
tissues recognize pathogen-associated molecular patterns (PAMPS) on the virus. 
Retinoic acid-inducible gene I (RIG-I) and the NOD-like receptors (NLRs) are also 
activated to respond to IAV infiltration upon their recognition of viral RNA or DNA 
(Rouse & Sehrawat, 2010). The activation of RIG-I is essential for the induction of the 
innate immune response to influenza A virus as it leads to a signaling cascade for the 
production of pro-inflammatory cytokines, type I interferons, antimicrobial peptides, 
and chemokines, as well as the recruitment of other inflammatory cells (Short et al., 
2014).  Importantly, the interferon response is believed to be essential for combating 
the replication of virus (Gack et al., 2007).  
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Interferons are induced by infected cells in order to up-regulate anti-viral 
mechanisms. Infected epithelial cells detect influenza A virus via the RIG-I/MAVS PRR. 
Viral detection leads to the activation of IRF7 (Crotta et al., 2013) and the induction of 
type I and III interferons, including IFN-, IFN-, and IFN- (Sommereyns et al., 2008). 
Type I IFNs, such as IFN- and IFN- are essential in the innate immune response to 
influenza infection (Muller et al., 1994); they signal through the JAK-STAT pathway to 
induce various interferon-stimulated genes such as protein kinase R (PKR) and 2′–5′ 
oligoadenylate synthetases (OAS) (Stark et al., 1998) the products of which go on to limit 
virus replication via the inhibition of host cellular translation, degredation of host and 
viral RNA, and disruption of the viral polymerase complex (Garcia-Sastre & Biron, 2006).  
While type 1 IFNs are expressed on all cell types, type III IFNs are primarily found on 
epithelial cells in the gastrointestinal and respiratory tract indicating they may act in a 
site-specific manner to induce innate immune responses to influenza A virus within 
epithelial tissue (Crotta et al., 2013).  This site specificity has been demonstrated in mice 
following viral infection where it was found that type I IFNs were robustly expressed in 
the brain following infection but type III expression was low and restricted to only 
epithelial cells at that site (Sommereyns et al., 2008). Unfortunately, the influenza virus 
has several mechanisms for manipulating host immune response and gene expression in 
order to dampen the interferon response.  
Influenza A virus limits type I IFN production by interfering with RIG-1 signaling. 
Viral NS1 protein prevents the translocation of IFR-3 and NF-B (Wang et al., 2000), this 
prevents the transcription of type I IFNs from occurring (Randall & Goodbourn, 2008). 
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By preventing IFN synthesis, influenza A virus can continue to replicate in host cells. The 
NS1 protein has also been shown to down regulate general host gene expression mainly 
through its interaction with host zinc finger domains on the nuclear cleavage and 
polyadenylation specificity factor (CPSF30) (Nemeroff et al., 1998). CPSF30 is necessary 
for processing the 3’ end of cellular pre-mRNA, without it RNA synthesis cannot occur 
(Nemeroff et al., 1998).  NS1 complexes with CPSF30 blocking the production of mature, 
polyadenylated host mRNAs (Fores et al., 1994). Host cells may try to respond to this 
disruption in host cell activities by inducing apoptosis; however, it has been 
demonstrated that influenza virus infected cells may be able to evade apoptosis due to 
down-regulation of type I IFNs (Zhirnov et al., 2002) by NS1. This is advantageous to the 
virus as it allows continued replication without being recognized and destroyed by the 
host immune system.  
 While it is believed that interferons are important for the innate immune 
response to virus, recent research has shown that other innate immune factors may 
activated by a novel pathway independent of and occurring before the interferons 
within the epithelial surface. Researchers infected wild-type C57BL/6 mice intravaginally 
with HSV-2 and then collected washes to look for viral mRNA as well as innate immune 
factors such as chemokines and cytokines (Iversen et al., 2016).  Type I and III 
interferons were not detected in the washes until two days post infection. However, 
CXCL9 and CXCL10 were detected a full 24 hours before any interferon production could 
be sensed (Iversen et al., 2016).  These two chemokines signal through the same 
receptor, CXCR3, and can be induced by interferons or other proinflammatory signals 
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(Groom & Luster, 2011). The authors of this study were ultimately able to show that it 
was the disruption of the mucosa by viral O-linked glycans that induced CXCL10 
production leading to the recruitment of neutrophils in order to protect the host 
(Iversen et al., 2016). Therefore, while interferons are important for response to IAV 
infection, there are other innate immune factors that act in defense of the host to viral 
infection.   
While the aforementioned immune factors are required for adequate control 
and elimination of viral infection, too much inflammation can lead to more severe 
disease. Dendritic cells, natural killer cells, and macrophages are necessary for the initial 
control of viral replication, but too robust a response can lead to destructive 
inflammation in the respiratory tract. In humans, non-human primates, and mice this 
has been demonstrated by examining lung pathology from individuals who succumbed 
to H5N1. Retrospective data from the 1918 H1N1 pandemic was also instrumental in 
demonstrating this observation (Peiris et al., 2009). Examination of both events reveals 
that cytokine and chemokine-induced inflammation in the lungs of infected individuals 
leads to respiratory distress that proved fatal in those infections (Kash et al., 2006).  
 
Influenza Epidemiology  
  Influenza viruses cause disease in one-tenth of the adult population of the world 
per year mostly through seasonal epidemics and, less frequently, through avian 
influenza outbreaks and pandemics (WHO, 2015).  The very young, the very old, 
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pregnant women, and individuals with compromised immune systems are at the highest 
risk of complications arising from influenza infection. Those who suffer from 
complications such as secondary bacterial infections are at increased risk of mortality, 
and, on average, between two and five hundred thousand people worldwide die from 
influenza per year (WHO, 2015). 
The sex of the infected individual may impact disease severity. Women of 
reproductive ages (i.e., between the ages of 18 and 45), experience greater morbidity 
and mortality when compared to age-matched men during epidemic, pandemic, and 
localized outbreaks. Case morbidity and mortality data from the H5N1 avian influenza 
outbreak in Asia demonstrates that women between the ages of ten to thirty-nine 
experience worse outcomes when compared to their male counterparts (Rabinowitz et 
al., 2010). Similarly, data from the initial wave of the 2009 H1N1 pandemic also show 
that women between the ages of 18 and 65 have increased incidence and severity of 
disease when compared to similar aged men (Klein et al., 2010). Most recently, the 
incidence of H7N9 avian influenza in China also shows that females of reproductive age 
are more likely than males to die from H7N9 (Bridges et al., 2003). In general, after 
puberty and prior to menopause, women experience worse influenza outcomes than 
age-matched men (Klein et al., 2010). 
The causes of increased susceptibility to influenza in women of reproductive 
ages are diverse and including both sex and gender associated variables. Sex refers to a 
person’s biological composition i.e. male, female or intersex. Gender refers to how a 
culture feels and behaves in reference to that person’s biological sex (Practice 
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Guidelines, 2011). Gender-associated factors, such as occupation, access and utilization 
of health care services, and hygiene may contribute to differential outcome from 
influenza between the sexes. In many countries, health workers, nurses, and primary 
school teachers are predominantly women. Women are also the primary care givers to 
young children in both developing and developed nations (Bridges et al., 2003). 
Healthcare patients and children in schools cluster, making disease transmission more 
likely, consequently those in closest contact are also at greatest risk for exposure to 
seasonal influenza viruses. In contrast, despite women being more likely to be 
hospitalized following exposure to avian influenza viruses (Fasina et al., 2015), men and 
women are at equal risk for exposure to avian influenza is via their contact with poultry. 
On larger farms or in commercial animal facilities, males make up the majority of the 
work force while women tend to homestead operations and smaller farms (Jagger et al., 
2012). Whether biological differences between men and women, including circulating 
sex steroids, contribute to differential risk of severe influenza is rarely considered in 
epidemiological and clinical studies. 
 
Sex-Specific Differences in Influenza  
Inflammation 
Male-female differences in infection may be caused by biological differences 
between men and women, including effects of endogenous sex steroid hormones on 
cellular function. Mice have been used to examine and model these differences. Using 
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murine adapted H1N1 and H3N2 in C57BL/6 mice, it was shown that female mice have 
lower lethal dose50 (LD50) levels when compared to their mass-equivalent male 
counterparts (Lorenzo et al., 2011). Female mice also had higher levels of neutralizing 
and total antibodies against both inoculation and primary infection than male mice 
(Lorenzo et al., 2011). Another study demonstrated that in adult male and female mice 
infected with a lethal dose of a mouse adapted H1N1 (A/Puerto Rico/8/1934; PR8), 
mortality was increased in females compared to males (Robinson et al., 2011).  Female 
mice began dying sooner than their male counterparts and experienced significantly 
more mortality over the course of the study (Robinson et al., 2011). Innate immune 
responses contribute to these differences seen between male and female mice. It has 
been demonstrated that PRRs from female mice, such as the TLRs, are more adept at 
detecting viral nucleic acids than male PRRs (Klein et al., 2010). It has also been shown 
that while IAV titers in the lungs of male and female mice are the same (Robinson et al., 
2011), the overall levels of pro-inflammatory cytokines and chemokines such as CCL2, 
TNF-, IFN- and IL-6 are greater in female mice than males (Larcombe et al., 2011). A 
difference in cytokine production, not viral titer, may contribute to the increased 
morbidity and mortality in female compared to male mice.    
Sex steroid hormones 
Endogenous sex steroid hormones have effects on the outcome of influenza 
infection. In female mice infected with H1N1, the estrous cycle is interrupted resulting 
in low circulating levels of estrogen and progesterone. This leads to an increase in NF-B 
transcription and resulting excessive expression of proinflammatory chemokines and 
12 
 
cytokines (Robinson et al., 2011). By administering estrogen to ovarectomized female 
mice during infection, pro-inflammatory chemokines and cytokines were suppressed 
increasing survival of the infected female mice (Robinson et al., 2011). In mice, estrogen 
exerted its effects through the ER- receptor, which is found on dendritic cells and 
macrophages, by suppressing NF-B activity (Robinson et al., 2011).  
In males, testosterone exerts effects on cells of the immune system. In cell 
culture it has been demonstrated that testosterone is anti-inflammatory, inhibiting the 
production of TNF- and nitric oxide while simultaneously inducing IL-10 (D’Agostino et 
al., 1999). The effect of testosterone on macrophages has also been examined in mice. It 
was demonstrated that in vitro exposure of murine macrophages to testosterone 
decreased the cell surface expression of Toll-like receptor 4, a necessary PRR for 
activation of the pro-inflammatory NF-B pathway. This pathway is necessary for the 
transcription of interferon producing genes a necessary factor in combating IAV 
infection (Rettew et al., 2008).  
Sex chromosomes 
Finally, in addition to gonadal hormones exerting a direct effect on immune 
effects, it has been proposed that genes found on the X and Y-chromosomes may 
impact sex-related differences in influenza pathogenesis. X-chromosome linked DEAD-
box helicase 3 (DDX3X) is a helicase that is necessary for the production of interferon 
(Soulat et al., 2008). Females have two copies of DDX3X while males have one copy of 
DDX3X and one copy of the Y-chromosome linked homologue. Studies have 
demonstrated that expression levels of homologous sex linked genes vary (Wilson & 
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Makova, 2009); females having two copies of DDX3X may therefore have increased 
levels of this helicase and subsequently greater IFN production (Muller et al., 2013).  
Studies on sex chromosomes and influenza A virus infection in four core 
genotype (FCG) mice have also demonstrated how sex steroids rather than the sex 
chromosome complement may mediate disease pathogenesis (Robinson et al., 2011). 
FCG mice have the Sry gene, a gene on the Y chromosome that is responsible for 
initiating testes formation and testosterone synthesis (Koopman et al., 1991), deleted 
and a Sry transgene inserted onto an autosome (Robinson et al., 2011). Infection with 
IAV in wild type gonadally intact females resulted in higher morbidity and mortality 
when compared to wild type gonadally intact males. This observed sex difference in 
gonadally intact mice disappeared when both sexes of mouse were gonadectomized 
(Robinson et al., 2011). FCG mice were gonadectomized and then infected with IAV; 
there was no observed difference in morbidity or mortality between the male and 
female mice. This result indicates that in this model sex hormones, not sex 
chromosomes, are responsible for the observed difference in IAV pathogenesis 
(Robinson et al., 2011).  
 
Aims and hypotheses 
While immortalized cell lines and mouse models have been used to examine the 
effects of sex on inflammation and infection, there has been little work done in humans. 
As a surrogate to infecting humans, primary human epithelial cell cultures can be used 
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to study the dynamics of influenza infection and host innate immune responses. In my 
project, I investigated differences in viral replication and the host innate immune 
responses following IAV infection in male and female differentiated human nasal 
epithelial cell (hNEC) cultures. Nasal cells are the first site of IAV infection, making them 
an excellent model to study IAV entry and early IAV replication kinetics (Muller et al., 
2013).  Previous work in hNECs characterized viral replication kinetics and proteins of 
the host cell following infection with live attenuated influenza virus (LAIV) as well as wild 
type strains (Fischer et al., 2015). It was demonstrated that there are replication kinetic 
differences of both LAIV and wild type in hNECs versus the immortal MDCK cell line. 
Furthermore, there were differences in M2 protein production in hNECs infected with 
LAIV versus the MDCK counterpart (Fischer et al., 2015). The use of hNECs over 
nonhuman MDCK cells allows us to better understand the human response to IAV 
infection and the innate immune effectors associated with influenza pathology.   
Furthermore, by looking at hNECs from both male and female donors sex comparisons 
of viral replication kinetics, cytokine and chemokine response, and other innate immune 









Madin-Darby canine kidney (MDCK) cells were propagated in Dulbecco's 
modified Eagle's low-phenol, high glucose medium (DMEM; Invitrogen) containing 10% 
fetal bovine serum (FBS; Life Technologies), 100 U/ml penicillin (Life Technologies), 100 
μg/ml streptomycin (Life Technologies), and 2mM L-Glutamine (Life Technologies). The 
cells were maintained at 37C in a humidified environment with 5% CO2. 
 
Virus 
The recombinant influenza A/Udorn/307/72 H3N2 virus used in this study was 
described previously (Pekosz et al., 2009). The hemagglutinin (HA) protein contains 
amino acid changes (HA L226Q/S228G in the H3 numbering system) that allows for 
preferential binding to α2,3-linked sialic acid. Viral working stocks of rUdorn α2,3 were 
generated by infecting MDCK cells at a multiplicity of infection (MOI) of approximately 
0.01 infectious units per cell in low-phenol, high glucose DMEM containing 0.25% bovine 
serum albumin (BSA; Life Technologies), acetylated trypsin from bovine pancreas 
(5μg/mL; N-acetyl trypsin; Sigma), 100 U/ml penicillin, 100 μg/ml streptomycin, 6mM L-
Glutamine, and 1mM Sodium Pyruvate (Life Technologies), which we refer to as 
infection media.  The infected cells were incubated at 37°C for 72 hours, infected cell 
supernatant was harvested, clarified by centrifugation at 500g for 10 minutes, aliquoted 
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and stored at -80C.  Infectious virus titers were determined by 50% tissue culture 
infectious dose (TCID50) as described previously (McCown & Pekosz, 2005). 
 
Human nasal epithelial cell (hNEC) cultures 
Primary human nasal epithelial cells were obtained from non-diseased human 
donor tissue during endoscopic sinus surgery. The cells were differentiated at an air-
liquid interface (ALI) in 24-well Falcon filter inserts (0.4-μM pore; 0.33cm2; Becton 
Dickinson) coated with human type IV placental collagen (Sigma-Aldrich) as described 
previously (Fischer et al., 2015; Kohanski & Lane, 2015; Bajic et al., 2003).  
 
Infection and treatment of hNEC cultures 
Prior to infection, the apical surface of hNEC cultures was washed with 
Dulbecco's phosphate-buffered saline with calcium and magnesium (DPBS; Life 
Technologies).   The cultures were infected via the apical chamber with a multiplicity of 
infection (MOI) of 1.0, 0.1, or 0.01 TCID50/cell or mock infected at 32°C in 200 ul of 
infection media.  After 2 hours, the inoculums were aspirated and the apical surfaces 
washed twice with DPBS before returning the cells to incubate at 32°C. At the indicated 
times post infection, 200 ul of infection media was added to the apical surface, 
incubated at 32°C for five minutes, then collected.  All samples were stored at -80°C 
until subjected to measurement of infectious viral production via TCID50 assay using 
MDCK cells or measurement of host immune factors via multiplex array analyses (Meso 
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Scale Discovery) and enzyme linked immunosorbent assays (ELISA).  Basolateral DMEM 
was collected and replaced with media containing fresh vehicle or compound at 48 and 
96hpi. 
 
Tissue Culture Infectious Dose (TCID50) assay 
MDCK cells were plated in a 96-well plate and cultured for 72 hours in growth 
DMEM until 90-100% confluent.  The cells were washed twice with DPBS, then covered 
with 180μL of infection DMEM.  Serial dilutions (10-1 to 10-8) of hNEC apical samples at 
each time-point were made in separate, 96-well plates by adding 20μL of each apical 
sample to 180μL of infection DMEM, then serially diluted 10 fold.  Twenty μL of each 
dilution was then added to the MDCK plates in replicates of six, resulting in final 
dilutions of each sample ranging from 10-2 to 10-9. The infection proceeded for 7 days at 
32°C, then the cells fixed with 4% formaldehyde and stained with napthol blue black 
solution (napthol blue black 1.6mM; sodium acetate 165mM; glacial acetic acid 60mL; 
qs to 1 liter). The cytopathic effect was scored visually and the Reed and Muench 
calculation was used to determine the titer of infectious virus at each time-point 
(McCown & Pekosz, 2005). 
 
Multiplex Assay Analysis 
The Meso Scale Discovery (MSD, Gaithersburg, MD) multiplex assay system was 
used to measure chemokines collected from apical and basolateral samples of hNECs 
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after infection.  In each well, the Chemokine Panel 1 kit quantitatively determined the 
concentration of eight C-C ligand motif (CCL2, CCL3, CCL4, CCL11, CCL13, CCL17, CCL22, 
CCL26) and two C-X-C ligand motif (CXCL8, CXCL10) chemokines, according to the 
manufacturer’s protocols. All samples were run in duplicate. MSD plates were read on 
the MSD SECTOR Imager 2400 at the Becton Dickinson Core Facility at the Johns Hopkins 
Bloomberg School of Public Health and analyzed on the accompanying software (MSD 
Discovery Workbench version 4). 
 
ELISAs 
The PBL Assay Science (Piscataway, NJ) DIY Human IFN Lambda 1/2/3 (IL-
29/28A/28B) was used to measure levels of interferon lambda (IFNλ) collected from 
apical and basolateral samples of hNECs after infection.  All samples were run in 
duplicate and read on the FilterMax F3 Multi-Mode Microplate Reader (Molecular 
Devices, Sunnyvale, CA). The data were analyzed with the accompanying software 
(SoftMax Pro Data Acquisition and Analysis Software). 
 
Microarray Analyses 
The microarray analyses were done using the Genomic Analysis and Sequencing 
Service Center Core Facility within the W. Harry Feinstone Department of Molecular 
Microbiology and Immunology. Trizol Reagent and the PureLink RNA Mini kit 
(Ambion/Life Technologies) were used for extraction and purification of RNA. Cells were 
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processed according to the manufacturer’s protocol including the on-column DNAse 
treatment. Following elution of purified RNA from the PureLink columns with Nuclease-
free water, quantitation was performed using a NanoDrop spectrophotometer and 
quality assessment determined by RNA Nano LabChip analysis on an Agilent BioAnalyzer 
2100 or RNA Screen Tape on an Agilent TapeStation 2200. One hundred nanograms of 
total RNA was processed for hybridization to Affymetrix Human Gene ST 2.0 microarrays 
using the Affymetrix GeneChip WT PLUS Reagent Kit according to the manufacturer’s 
recommended protocol. Hybridization was performed at 45oC for 16 hours at 60 rpm in 
the Affymetrix rotisserie hybridization oven.  The signal amplification protocol for 
washing and staining of eukaryotic targets was performed in an automated fluidics 
station (Affymetrix FS450) using Affymetrix protocol FS450_0002.  The arrays were 
scanned in the GCS3000 laser scanner with autoloader and 3G upgrade (Affymetrix). 
Quality assessment of hybridizations and scans was performed with Expression Console 
software (Affymetrix).  
 
Statistical Analyses 
Data were expressed as means +/- standard error of the mean (SEM), and 
multiple comparisons between experimental groups were made using multivariate 
analysis of variance (MANOVA) and/or analysis of variance (ANOVA) followed by Tukey’s 
post hoc comparisons, when appropriate.  For microarray analyses, Partek Genomics 
Suite version 6.6 was used for detailed statistical analysis. The RMA (Robust Multi-chip 
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Average) Algorithm was used for background correction, normalization, and 
summarization of probes. Analysis of Variance (ANOVA) with linear contrasts was 
performed to generate p-values and fold changes; numerous plots (PCA, Volcano, 
Interaction, Dot, etc); and creation and querying of gene lists. At least three separate 
experiments were conducted for each treatment prior to data analysis.  Statistical 
















rUdornα2,3 replication kinetics are not different in hNECs derived from 
male and female donors 
 To test the hypothesis that viral replication kinetics might differ depending on 
the sex of the donor cell, primary human nasal epithelial cell (hNEC) cultures from male 
and female donors of reproductive age were infected with A/Udorn/307/72 H3N2 α2,3 
(rUdorn α2,3) at an MOI of 0.1. Apical supernatant samples were taken every 24 hours 
for 5 days to measure virus titers (Fig. 1). Peak virus replication occurred at roughly 72 
hours post infection in hNECs from both male and female donors. Both the replication 
kinetics and peak virus titers were similar in hNECs derived from male and female 
donors. These data indicate that following rUdorn α2,3 infection, replication kinetics in 
hNECs do not differ between the sexes. Because sex differences in the outcome of 
influenza are reported in humans (Klein et al., 2010; Rabinowitz et al., 2010) and animals 
(Robinson et al., 2011), we hypothesize that sex differences in the outcome of infection 
may be the result of differences in the host response to infection.  
  
Interferon-λ production is greater in hNECs from females compared to 
males 
 Interferon- λ is the primary IFN produced by respiratory epithelial cells in 
response to infection with IAVs (Crotta et al., 2013). To test the hypothesis that primary 
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hNEC cultures produce IFN- λ following infection with a H3N2 virus that preferentially 
binds α2,3, hNECs from female and male donors were infected with rUdorn α2,3  at an 
MOI of 0.1 and apical and basolateral supernatant samples were taken every 24 and 48 
hours respectively following infection. Detectable interferon-λ production was observed 
at 96 hours post infection in both apical (Fig. 2A) and basolateral samples (Fig. 2B). Both 
apical and basolateral samples from rUdorn α2,3-infected cells, regardless of sex, 
produced more IFN- λ than the mock-infected samples.  Overall, basolateral production 
of IFN-λ was greater than apical IFN-λ production regardless of the sex of the hNECs 
donor. In the apical supernatants (Fig. 2A), hNECs from females produced significantly 
more IFN-λ when compared to cells from their male counterparts. This sex difference in 
production was not seen in the basolateral samples (Fig. 2B). Taken together, these data 
suggest that there is increased production of apical IFN-λ in hNECs from female donors.   
 
Chemokine production following rUdorn α2,3 infection is more robust in 
hNECs from male donors than female donors 
 During IAV infections, chemokines are produced by epithelial cells to signal 
immune cells to the site of infection (Iversen et al., 2016; Groom & Luster, 2011). To test 
the hypothesis that chemokine production might differ in cells derived from male or 
female donors, we examined chemokine production in apical samples from hNEC 
cultures at 48, 72, and 96 hours post infection. The chemokine panel used for the 
analysis contained the following ten chemokines: CCL11, CCL26, CCL2, CCL13, CCL22, 
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CCL3, CCL4, CCL17, CXCL8, and CXCL10.  We first compared rUdorn α2,3-infected to 
mock-infected hNEC cultures within each sex. Of the ten chemokines examined, rUdorn 
α2,3-infected hNECs from females produced all but CCL26, CXCL8, CCL2, and CCL13 at 
levels significantly greater than mock (Table 1A) while males produced all but CCL26 and 
CCL13 at levels significantly greater than mock (Table 1B).  These data suggest that 
within each sex there is an increase in chemokine production in response to rUdorn α2,3 
infection in hNECs from derived from both male and female donors,  but possibly to a 
greater extent in cultures from males. 
To test the hypothesis that there is differential expression of chemokines 
between the sexes, the expression levels of each chemokine examined (Tables 1A, 1B) 
from rUdorn α2,3 –infected cultures was normalized to same sex mock-infected cultures 
and then compared between the sexes. After normalization, hNECs from male donors 
produced significantly more CXCL10, CCL17, CCL2, and CCL22 at the various time points 
post-infecgtion than hNECs from female donors. These four chemokines are important 
for the IFN response to infection as well as the recruitment of immune cells in response 
to infection (De Paepe et al., 2009). In contrast, the only chemokine that was produced 
at higher concentrations in hNECs from female donors as compared to males was 
CCL11, which is generally associated with allergic type responses (Graziano et al., 1999). 
These data demonstrate that males produce a more robust and varied chemokine 
response to IAV infection when compared to hNECs from female donors. Furthermore, 
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the function of the chemokines released in response to IAV infection may also differ 
between the sexes.  
 
Transcriptional activity in hNECs during rUdorn α2,3 infection is greater in 
cultures derived from male than female donors 
 To more fully characterize sex differences in host cellular response to rUdorn 
α2,3 infection, we conducted global transcriptional analyses using microarrays. For the 
initial analysis, the RMA Algorithm was used for background correction, normalization, 
and summarization of probes. An ANOVA with linear contrasts was then performed to 
genes that were differentially expressed either 24 or 48 hours post-infection. At 24 
hours post infection (Figure 4A), only 15 of the roughly 35,000 genes probed on the 
microarray were differentially expressed between rUdorn α2,3-infected hNECs from 
male and female donors. In contrast, at 48 hours post infection (Table 2B) there were 
826 differentially expressed genes following rUdorn α2,3 infection in hNECs from male 
and female donors. Furthermore, there were 451 and 578 differentially expressed genes 
in IAV infected hNECs compared to mock-infected cultures derived from male and 
female samples respectively (Figure 4B). 
For the second analysis, RMA was performed and then rUdorn α2,3-infected 
cultures were normalized to same sex mock-infected cultures to control for baseline 
differences between the sexes prior to infection. Following normalization, an ANOVA 
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was performed in order to detect genes that were differentially expressed between the 
sexes during infection. Following this analysis, only 16 genes (Figure 4B) were 
differentially expressed 24 hours post infection between hNECs from male and female 
donors. By 48 hours post infection, 780 genes were differentially expressed between the 
sexes (Figure 4B). The same intrinsic sex differences in gene expression following 
infection were also observed in the normalized data at 48 hours post infection (Figure 
4B). Furthermore, there were 492 differentially expressed genes in both normalized and 
non-normalized data sets at 48 hours post infection (Figure 4C). These data indicate that 
the transcriptional responses of hNECs from male and female donors differ in a time-
dependent manner following rUdorn α2,3 infection.  
 
Transcriptional activity along pathways associated with immune system 
processes is higher in hNEC cultures derived from males than females 
 Because we observed the greatest number of differentially expressed genes 48 
hours post-infection, we utilized data from this time point and performed a Gene-
Ontology (GO)-enrichment to determine the biologically relevant pathways that were 
differentially activated between the sexes following rUdorn α2,3 infection. An 
enrichment score of ≥ 3 is considered statistically significant with a greater score 
indicating a stronger association of the gene set to that biological function. Regardless 
of whether data were not normalized to same-sex mock-infected cultures (Figure 5A) or 
were normalized to same-sex mock-infected cultures (Figure 5B) the top three 
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biologically relevant pathways that showed significant activation following infection 
included immune system process, response to stimulus, and multi-organism process. 
Along each of these pathways transcriptional activity was generally higher in hNECs 
derived from male than female donors. Using hierarchal clustering, which is an unbiased 
method for assessing the relationships between individual gene expression patterns and 
discerning how genes group together independent of sex or infection status, we 
demonstrated (Figure 5C) that gene expression patterns cluster by both sex and 
infection status.   These data indicate that hNECs from male donors have greater 
differential gene expression of genes associated with these three biological functions 
when compared to hNECs from female donors.  
Within the immune system process genes that were differentially expressed 
between the sexes 48 hours post-infection, there were 137 common genes that were 
differentially expressed between the sexes when expression data either were or were 
not normalized to same sex mock-infected cultures. A majority of these 137 genes were 
associated with pattern recognition receptor activity, IFN signaling, and inflammatory 
responses (Fig 6). At 48 hours post rUdorn α2,3 infection, hNECs from male donors had 
a greater proportion of upregulated immune response genes than their female 
counterparts. Of the genes that were upregulated in hNEC cultures from males, these 
genes were generally associated with antiviral responses to IAV infection including IRF7, 
DDX58, and CXCL10 (Rouse & Sehrawat, 2010; Crotta et al., 2013; Iversen et al., 2016). 
In contrast, the few genes with higher levels of expression in cultures derived from 
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females included KIT, CD36, and KIF2C, none of which are known to be involved in the 
innate immune response to IAV (Roberts & Govender, 2015; Smith et al., 2012; Wang et 
al., 2015). Taken together, these data suggest that activity along antiviral pathways are 

























Figure 1: Effect of sex on the outcome of recombinant influenza A/Udorn/307/72 
H3N2 rUdorn α2,3 infection in hNECs from female and male donors. hNECs from 
donors between the ages of 16-45 were infected with rUdorn α2,3 (MOI = 0.1 
TCID50/cell) via the apical membrane. Apical samples were obtained 2, 24, 48, 72, and 96 
hours post infection (n=13 female donors, n=10 male donors). Viral titers were analyzed 
at these time points by TCID50. Data shown are the mean ± SEM. The dashed line 
represents the limit of detection by TCID50. There was no difference in viral replication 





















Figure 2: Effect of sex on apical and basolateral interferon lambda (IFN-λ) production. 
hNECs from male and female donors were infected with rUdorn α2,3 (MOI = 0.1 
TCID50/cell)  or mock-infected via the apical membrane.  Apical (A) and basolateral (B) 
samples were examined for IFN-λ production 96 hours post infection (n=5 donors per 
sex). Data shown are the mean ± SEM. *p≤ 0.01. hNECs from female donors produced 
statistically significantly more IFN-λ apically than their male counterpart while there was 
no sex difference in the basolateral production of IFN-λ. Both sexes produced more IFN-









Table 1: rUdorn α2,3-induced chemokines in hNECs from male and female donors 48, 
72, and 96 hours post infection. hNECs from male and female donors were infected 
with rUdorn α2,3 or mock-infected (MOI = 0.1 TCID50/cell) via the apical membrane. 
Apical samples from female (A) and male (B) hNECs were examined for chemokine 
production (n=5 donors per sex) at 48, 72, and 96 hours post infection. Data shown are 
the mean ± SEM. Bolded values denote p<0.05 for samples from infected compared 
with mock-infected cultures. There is differential production of several chemokines 
following rUdorn α2,3 infection with hNECs from males showing greater production of 























Figure 3: Effect of sex on chemokines production in response to rUdorn α2,3 infection 
at various time points post-infection. The concentration of chemokines from infected 
hNECs derived from males or females (Table 1) were normalized to their respective 
mock-infected cultures and then compared between the sexes at each of the time 
points (n=5 donors per sex). Data shown are the mean ± SEM. Asterisks (*) denote 
p<0.05.  hNECs from male donors produced statistically significantly more CXCL10, 
CCL17, CCL22, and CCL2 than their female counterparts. CCL11 was the only chemokine 





























            
Figure 4: Differentially expressed genes in cultures 24 and 48 hours rUdorn α2,3-
infection. hNEC cultures from male and female donors were infected with IAV (MOI = 







RNA isolated and spotted onto Affymetric Human GeneST2.0 arrays. The number of 
differentially expressed genes were calculated based on RMA normalization only (A) or 
RMA normalization following normalization of infected cultures to same-sex mock-
infected cultures (B). Using either analysis, there were a limited number of differentially 
expressed genes at 24 hours post infection and a much greater number of differentially 
expressed genes 48 hours post infection. Those differentially expressed genes were 

































































Figure 5: GO enrichment and hierarchical clustering of genes differentially expressed 
in cultures from male and female donors 48 hours post rUdorn α2,3-infection. hNEC 
cultures from male and female donors were infected with rUdorn α2,3 (MOI = 0.1 
TCID50/cell) via the apical membrane. At 24 and 48hpi, cells were harvested and RNA 
isolated and spotted onto Affymetric Human GeneST2.0 arrays. Following identification 
of differentially expressed genes via ANOVAs in Partek Genomic Suit version 6.0, a GO-
enrichment was performed on RMA normalized (A) and data normalized with RMA and 
to same-sex mock infected cultures (B). Using GO enrichment, in both sets of data 
immune system processes, response to stimulus, and multi-organism processes were 
the top three differentially activated pathways. A heat map (C) was also generated using 
the list of 137 genes differentially expressed between the sexes 48 housr post rUdorn 
α2,3-infection to evaluate the unbiased clustering of these genes which clearly clustered 



















Table 2: 137 genes that were differentially expressed between the sexes 48 hours post 
infection. Using the results of the GO-enrichment of RMA normalized and data 
normalized with RMA and to same-sex mock infected cultures, a list of 137 differentially 
expressed immune system process genes between hNECs from male and females was 
derived from both data sets. Fold change and ratio values represent the comparison of 







(Male vs Female) 
Ratio 
(Male vs Female) 
ISG15 4.74E-14 10.9269 1.09E+01 
THEMIS2 2.08E-05 2.30106 2.30E+00 
TINAGL1 0.000119531 3.81586 3.81586 
KIF2C 5.93E-05 -2.06742 4.84E-01 
IFI44L 1.73E-08 14.1501 1.42E+01 
IKBKE 0.000400793 2.08585 2.08585 
IL19 1.18E-09 4.13149 4.13E+00 
CD55 5.47E-05 2.06829 2.06829 
IFI6 6.21E-08 9.45863 9.46E+00 
GBP1 1.08E-09 4.56431 4.56E+00 
GBP2 1.70E-13 4.9136 4.91E+00 
GBP2 2.17E-09 3.73138 3.73E+00 
S100A12 4.96E-05 3.1957 3.20E+00 
IFIT2 1.01E-11 17.8527 1.79E+01 
IFIT3 2.07E-10 12.4106 1.24E+01 
IFIT1 3.86E-10 12.8766 1.29E+01 
IFIT5 9.02E-10 3.07857 3.08E+00 
KLF6 0.000146291 2.49704 2.49704 
IFITM2 1.68E-06 3.11051 3.11E+00 
IFITM1 3.98E-08 4.68754 4.69E+00 
TRIM22 2.59E-10 3.69981 3.70E+00 
SAA1 0.000646168 4.25031 4.25031 
BIRC3 1.16E-07 3.98143 3.98E+00 
IFITM3 3.20E-09 3.00073 3.00E+00 








(Male vs Female) 
Ratio 
(Male vs Female) 
TRIM21 1.61E-10 2.76544 2.77E+00 
TRIM5 2.89E-12 2.7699 2.77E+00 
UBE2L6 3.61E-09 2.91627 2.92E+00 
MMP1 0.000246888 3.09477 3.09477 
POU2AF1 1.90E-07 -2.89443 3.45E-01 
ETS1 0.000240145 2.24002 2.24002 
IRAK3 9.57E-07 4.54795 4.55E+00 
OAS1 1.45E-10 7.74695 7.75E+00 
OAS3 5.98E-12 9.76151 9.76E+00 
OAS2 1.78E-12 6.33946 6.34E+00 
STAT2 1.06E-09 2.88321 2.88E+00 
DUSP6 0.000627573 2.22598 2.22598 
OASL 3.07E-13 11.0529 1.11E+01 
IRF9 5.04E-09 2.24848 2.25E+00 
ADSSL1 9.66E-07 -2.61492 3.82E-01 
THBS1 1.33E-05 9.42514 9.43E+00 
GCNT3 3.97E-05 3.40362 3.40E+00 
PML 5.78E-09 3.25678 3.26E+00 
ISG20 5.42E-10 2.10193 2.10E+00 
IL4R 0.000712604 2.0745 2.0745 
CCL22 4.38E-08 2.45199 2.45E+00 
CX3CL1 0.00013702 2.48464 2.48464 
SLC7A5 0.000278307 5.94704 5.94704 
ITGA3 0.000323013 2.00481 2.00481 
CXCL16 7.58E-07 2.8758 2.88E+00 
CCL5 8.17E-14 3.55677 3.56E+00 
DHX58 3.63E-08 2.26435 2.26E+00 
TRIM25 9.22E-08 2.46898 2.47E+00 
SECTM1 4.01E-05 3.05476 3.05476 
PMAIP1 7.63E-05 2.16042 2.16042 
ICAM1 2.20E-10 7.27738 7.28E+00 
HSH2D 5.07E-11 2.7941 2.79E+00 
IFNL2 3.76E-12 10.6675 1.07E+01 
IFNL1 1.76E-10 3.05895 3.06E+00 
CEACAM6 0.00087449 3.80777 3.80777 
SBNO2 1.42E-05 2.14561 2.15E+00 
C3 1.97E-05 4.1205 4.12E+00 
BST2 2.25E-07 3.44785 3.45E+00 








(Male vs Female) 
Ratio 
(Male vs Female) 
RSAD2 3.16E-12 14.6518 1.47E+01 
IL1R1 5.98E-07 2.58576 2.59E+00 
IL36G 0.000814683 3.17868 3.17868 
CCL20 1.21E-12 7.38449 7.38E+00 
EIF2AK2 5.40E-15 3.08014 3.08E+00 
IGKC 0.0019081 3.68353 3.68353 
IL1A 1.02E-07 18.3396 1.83E+01 
IL1B 3.48E-05 4.76522 4.77E+00 
DPP4 0.000101033 2.38703 2.38703 
IFIH1 2.62E-14 6.56558 6.57E+00 
STAT1 4.35E-12 4.14128 4.14E+00 
BPIFA1 0.000220435 -5.23847 0.190895 
ZBP1 3.10E-09 2.23504 2.24E+00 
MX2 7.17E-09 2.86843 2.87E+00 
MX1 4.31E-13 4.55046 4.55E+00 
IGLC1 4.96E-12 2.87579 2.88E+00 
APOL1 1.93E-11 4.4137 4.41E+00 
APOBEC3A 0.000193241 2.04818 2.05E+00 
LIF 0.000152276 2.17405 2.17405 
IRAK2 3.87E-06 2.41458 2.41E+00 
KIF15 0.000111762 -2.42838 4.12E-01 
POLQ 0.000169072 -2.48758 0.401996 
PLSCR1 5.21E-09 2.58139 2.58E+00 
LAMP3 1.10E-16 6.75476 6.75E+00 
KIT 1.24E-07 -7.69578 1.30E-01 
EREG 3.16E-05 6.1667 6.17E+00 
ANXA3 1.87E-06 3.5699 3.57E+00 
HERC5 6.45E-11 10.6909 1.07E+01 
CXCL5 4.03E-05 11.9589 1.20E+01 
CXCL3 0.00053429 2.31011 2.31011 
CXCL9 9.80E-11 29.4025 2.94E+01 
CXCL10 9.44E-12 127.751 1.28E+02 
CXCL11 9.54E-15 48.304 4.83E+01 
SNCA 7.77E-09 -2.72397 3.67E-01 
TNIP3 3.72E-08 2.99741 3.00E+00 
DDX60 1.03E-10 5.36791 5.37E+00 
SPEF2 0.000227991 -2.59144 0.385886 
CYFIP2 2.44E-06 -2.58712 3.87E-01 








(Male vs Female) 
Ratio 
(Male vs Female) 
IRF1 7.51E-09 2.37927 2.38E+00 
CXCL14 1.95E-05 3.4451 3.45E+00 
HLA-H 5.64E-05 2.33438 2.33438 
CFB 1.26E-06 7.11924 7.12E+00 
PSMB9 0.000199465 2.05177 2.05177 
MYB 0.000101859 -2.25607 0.443249 
UBD 0.000549427 4.18173 4.18E+00 
TRIM31 0.00188772 2.71734 2.71734 
TAP2 5.72E-10 3.06569 3.07E+00 
PSMB8 7.57E-07 2.00503 2.01E+00 
TAP1 3.68E-12 4.77759 4.78E+00 
BAK1 6.43E-07 2.03942 2.04E+00 
AKIRIN2 7.25E-05 2.23126 2.23126 
VNN1 2.33E-06 2.07625 2.08E+00 
C2 2.65E-05 3.02813 3.03E+00 
C2 2.52E-05 2.9825 2.98E+00 
C2 4.64E-05 2.75428 2.75E+00 
C2 2.52E-05 2.9825 2.98E+00 
HLA-A 4.98E-05 2.0267 2.0267 
C2 2.60E-05 2.96166 2.96E+00 
C2 2.58E-05 3.09803 3.10E+00 
CD36 3.14E-07 -3.73752 2.68E-01 
SLC7A2 5.30E-05 -3.38513 0.29541 
CLU 8.42E-05 -2.243 4.46E-01 
ENPP2 3.21E-05 -2.33398 0.428452 
LY6D 1.01E-05 3.2538 3.25E+00 
CD274 1.08E-09 5.85351 5.85E+00 
PDCD1LG2 4.36E-06 2.81719 2.82E+00 
LCN2 3.50E-07 6.69306 6.69E+00 
IFNB1 1.22E-11 3.87632 3.88E+00 
DDX58 9.96E-12 5.48656 5.49E+00 
TRIM14 2.42E-06 2.19151 2.19E+00 

















Figure 6: Genes along pattern recognition receptor and antiviral pathways were 
differentially expressed in hNECs from male versus female donors at 48 hours post 
rUdorn α2,3-infection. Using the list of 137 genes that were differentially expressed 
between the sexes 48hpi (Table 2), we imported the gene list into Ingenuity Pathway 
Analyses to identify pathways and the biological relationships between differentially 
expressed genes (B). Significant upregulation (127.75 to 2.00 fold change) in hNECs from 
males is illustrated in gradations of red and significant downregulation (-2.06 to -7.69 




























In this study, the donor sex of hNECs affected the host response to rUdorn α2,3-
infection. While the donor sex of hNECs did not affect viral replication titers, it did 
influence the host cellular response to infection including production of IFN-λ and 
chemokines and the transcriptional activity of antiviral genes in hNECs. Overall, hNECs 
from males demonstrated higher antiviral activity after infection with rUdorn α2,3 IAV 
than their female counterparts. 
There was no effect of donor sex on rUdorn α2,3 replication in hNECs, which is 
consistent with what has been reported in mouse studies of influenza A virus infection 
(Robinson et al., 2011). This result is counter to studies of other viruses such as HIV and 
Hepatitis B virus (HBV), which report differences in virus replication based on sex. Sex 
differences in HIV and HBV replication have been reported previously with Farzadegan 
and colleagues (1998) demonstrating that the HIV viral load in plasma is lower in female 
patients than males with the same CD4 T cell count. Despite differences in viral titers, 
the time to AIDS is the same for men and women after adjusting for CD4 T cell counts.  
Sex differences in plasma viral load and progression to AIDS is reported in other studies 
(Sterling et al., 2001), further confirming that HIV replicates differently in men and 
women resulting in differential progression of disease. Similar to HIV infection, men 
infected with HBV have greater viral titers in their sera than their female counterparts 
(Wang et al., 2009). Additionally, in studies of individuals with HBV, men and post-
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menopausal women tend to progress through the stages of cirrhosis faster than infected 
women of reproductive age (Wang et al., 2009). In both HIV and HBV, males have 
greater viral titers in their sera than females yet females have the same or more rapid 
disease progression.   
Sex differences in cellular responses to viruses have also been noted. For 
example, HIV replication is higher in peripheral blood mononuclear cells (PBMCs) and 
monocyte-derived dendritic cells (MDDCs) from male then female donors of 
reproductive age (25-45). Furthermore, HIV and HBV cause chronic infection 
(Farzadegan et al., 1998; Wang et al., 2009), whereas IAV causes an acute infection 
(WHO, 2015), meaning the kinetics of virus replication are different. Whether sex 
differences are more apparent in response to chronic viral infection as opposed to acute 
viral infections should be considered. Additionally, where within the cell these viruses 
replicate could be another factor influencing sex-specific outcomes. 
Sex differences in antiviral responses to virus have been shown previously. For 
example, Griesbeck and colleagues (2015) stimulated plasmacytoid dendritic cells (pDCs) 
from healthy male or female donors with an HIV TLR7/8 ligand to examine the percent 
of pDCs producing IFN-α . They found that a significantly higher percentage of IFN-α 
producing pDCs were present following HIV stimulation in females than males 
(Griesbeck et al., 2015). In disease models, progesterone has been shown to increase 
IFN-α secretion by pDCs in response to HIV-1 derived TLR7/8 ligand stimulation (Meier 
et al., 2009). Studies utilizing RNA isolated from T-cells or DCs show that the expression 
of genes such as MX1 and CCR5 involved in TLR recognition of HIV infection and IFN-α 
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pathway are higher in females than males, which is associated with higher levels of 
immune activation (Chang et al., 2013). Finally, studies of pDCs from human male and 
female donors have shown that basal levels of IRF5, a mediator of TLR7 signaling, is 
higher in females than males which correlated with the percentage of INF- α secreting 
pDCs (Griesbeck et al., 2015). In our study females produced higher levels of IFN-λ, 
which is the main interferon produced in epithelial cells. Higher production of IFN-α by 
immune cells and greater production of IFN-λ by hNECs occur in cells from female as 
compared with male donors.  While females produced higher levels of IFN-λ, they had 
lower levels of transcriptional IFN-λ activity. This may be due to the immunosuppressive 
role of testosterone. Males may need to upregulate IFN-λ transcriptional activity to a 
greater extent than their female counterparts in order to overcome the immune 
suppression on IFN-λ from testosterone.  
In 2014, the National Institutes of Health (NIH) announced policies in regards to 
sex as a variable in preclinical research (Clayton & Collins, 2014). Prior to this mandate, 
there had been numerous studies that demonstrated a sex difference in disease or 
treatment outcome both in cell culture (Mittelstrass et al., 2011; Penaloza et al., 2009) 
as well as animal models (Du et al., 2014) yet many researchers were not aware of the 
sex of their cells or were failing to report them (Pollitzer, 2013). Since October 2014, 
researchers applying for NIH funding must now address how they plan to include male 
and female cells and animals in their research protocols. Additional funding and 
oversight committees have also been introduced to help with this transition and to 
ensure the compliance of researchers to the new guidelines (Clayton & Collins, 2014).  
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For the purposes of my project, I was interested in examining the reporting of 
the sex of epithelial cells used in IAV research. I conducted a literature search using 
PubMed with the search input, “in vitro influenza infection epithelial cells.” Of the 395 
results, I examined 120 articles that were all published between 2010 and 2016. Of the 
120 articles, only 34 reported the use of human epithelial cells in their work as opposed 
to epithelial cells derived from either animals or immortalized cell lines. Furthermore, of 
those 34 articles, only 5 reported using cells from both male and female donors. The 
most important result of this literature review was the discovery that none of the 
articles that I reviewed considered sex as a variable when conducting their research or 
stratified their results by sex. This result underscores how little is currently known about 





pathogenesis of IAV in primary cell cultures, specifically epithelial cells. It also 
demonstrates how important it is to conduct studies such as mine because there is not 




The investigation of the mechanism accounting for the observed sex differences 
in immune factor production and transcriptional activity between hNECs from male and 
female donors would be the next logical experimental step. In order to do this, an 
A/Udorn/72 NS1 mutant could be used to help investigate if the observed sex 
differences are occurring because of something the virus is inhibiting versus how the 
cells are responding to infection. Viral NS1 has several mechanisms by which it 
interferes with the host response to IAV infection including preventing type I IFN 
transcription and downregulating host gene expression via a complex with CPSF30 
(Wang et al., 2000; Randall & Goodbourn, 2008; Nemeroff et al., 1998). If we repeated 
the viral replication, chemokine/cytokine production, and microarray analysis following 
infection with the NS1 mutant virus and the sex difference was still present, this would 
indicate that there is a sex difference in the response to IAV infection not a sex 
difference in which the virus inhibits cellular mechanisms in the host cell. If the sex 
difference I observed in my studies disappears using the NS1 mutant, this would 
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indicate that the sex differences is due to the virus inhibiting something in hNECs 
derived from female donors leading to the sex difference I observed.  
 Another potential experiment would be to look at the immunosuppressive role 
of testosterone in IAV infection. Previous work in our lab has shown that testosterone 
suppresses the innate immune response to infection with IAV in male mice. My study 
demonstrated chemokine production and transcriptional activity was higher in hNECs 
from male donors. I would like to investigate if this is due to a lack of circulating 
endogenous male hormones within the hNEC culture system that; within the nose 
epithelial cells may need to upregulate their transcriptional activity in order to 
overcome the endogenous hormones. If I were to treat my cells with testosterone and 
then infect them with IAV and see a dampening of their innate immune response, this 
may explain why my hNECs from male donors seemingly have a greater transcriptional 



















Bajic VB, Tan SL, Chong A, Tang S, Strom A, Gustafsson JA, Lin CY, Liu ET. Dragon ERE 
Finder version 2: A tool for accurate detection and analysis of estrogen response 
elements in vertebrate genomes. Nucleic acids research. 2003;31(13):3605-7. Published 
Online 2003 June 26. PubMed PMID: 12824376; PMCID: Pmc168924. 
 
Bridges CB, Kuehnert MJ, Hall CB. Transmission of influenza: implications for control in 
health care settings. Clinical Infectious Diseases. 2003, 37:1094– 1101. Published Online 
2003 September 19. PubMed PMID: 14523774.  
 
Chang JJ, Woods M, Lindsay RJ, Doyle EH, Griesbeck M, Chan ES, Robbins GK, Bosch RJ, 
Altfeld M. Higher expression of several interferon-stimulated genes in HIV-1-infected 
females after adjusting for the level of viral replication. Journal of Infectious Diseases. 
2013; 208(5): 830-838. Published Online 2013 June 10. doi: 10.1093/infdis/jit262. 
PubMed PMID: 23757341. 
 
Clayton JA, Collins FS. Policy: NIH to balance sex in cell and animal studies. Nature. 2014; 
509(7500): 282-283. PubMed PMID: 24834516. 
 
Crotta S, Davidson S, Mahlakoiv T, Desmet CJ, Buckwalter MR, Albert ML, Staeheli P, 
Wack A. Type I and type III interferons drive redundant amplification loops to induce a 
transcriptional signature in influenza-infected airway epithelia. PLoS Pathogen. 2013; 
9(11): e1003773. doi: 10.1371/journal.ppat.1003773. Published Online 2013 November 
21. PubMed PMID: 24278020. 
 
D’Agostino P, Milano S, Barbera C, Di Bella G, La Rosa M, Ferlazzo V, Farruggio R, Miceli 
DM, Miele M, Castagnetta L, Cillari E. Sex hormones modulate inflammatory mediators 
produced by macrophages. Annals of the New York Academy of Sciences. 1999; 876: 
426-429. PubMed PMID: 10415638. 
 
De Paepe B, Creus KK, De Bleecker JL. Role of cytokines nad chemokines in idiopathic 
inflammatory myopathies. Current Opinions in Rhumatology. 2009; 21(6): 610-616. doi: 
10.1097/BOR.0b013e3283317b31. PMID: 19726994. 
 
Du S, Itoh N, Askarinam S, Hill H, Arnold AP, Voskuhl RR. XY sex chromosome 
complement, compared with XX, in the CNS confers greater neurodegeneration during 
experimental autoimmune encephalomyelitis. Proceedings of the National Academy of 
Sciences of The United States of America. 2014; 111(7): 2806-2811. Published Online 
2014 February 3. doi: 10.1073/pnas.1307091111. PubMed PMID: 24550311. 
 
Eccles, R. Understanding the symptoms of the common cold and influenza. The Lancet 
49 
 
Infectious Diseases. 2005; 5(11): 718-725. PMID: 16253889. 
Farzadegan H, Hoover DR, Astemborski J, Lyles CM, Margolick JB, Markham RB, Quinn 
TC, Vlahov D. Sex differences in HIV-1 viral load and progression to AIDS. The Lancet. 
1998; 352(9139): 1510-1514. PubMed PMID: 9820299. 
 
Fasina FO, Ifende VI, Ajibade AA. Avian influenza A(H5N1) in humans: lessons from 
Egypt. European Surveillance. 2010: 15(4): 19473. PubMed PMID: 20122384.   
 
Fischer, WA 2nd, King LS, Lane AP, Pekosz A. Restricted replication of the live attenuated 
influenza A virus during infection of primary differentiated human nasal epithelial cells. 
Vaccine. 2015; 33(36): 4495-4504. doi: 10.1016/j.vaccine.2015.07.023. Published Online 
2015 July 18. PubMed PMID: 26196325. 
 
Fortes P, Beloso A, Ortin J. Influenza virus NS1 protein inhibits pre-mRNA splicing and 
blocks mRNA nucleocytoplasmic transport. The EMBO Journal. 1994; 13(3): 704-712. 
PubMed PMID: 8313914.  
 
Gack MU, Shin YC, Joo CH, Urano T, Liang C, Sun L, Takeuchi O, Akira S, Chen Z, Inoue S, 
Jung JU. TRIM25 RING-finger E3 ubiqutin ligase is essential for RIG-I-mediated antiviral 
activity. Nature. 2007; 446(7138): 916-920. PubMed PMID: 17392790.  
 
Garcia-Sastre A, Biron CA. Type I interferons and the virus-host relationship: a less in 
détente. Science. 2006; 312(5775): 879-892. PubMed PMID: 16690858. 
 
Gorbach SL, Bartlett JG, Blacklow NR. 2014. Infectious Diseases. 3rd ed. Philadelphia: 
Lippincott Williams & Wilkins.  
 
Gorman OT, Bean WJ, Kawaoka Y, Donatelli I, Guo YJ, Webster RG. Evolution of influenza 
A virus nucleoprotein genes: implications for the origins of H1N1 human and classical 
swine viruses. Journal of Virology. 1991; 65(7): 3704-3714. PubMed PMID: 2041090.  
 
Graziano FM, Cook EB, Stahl JL. Cytokines, Chemokines, RANTES, and Eotaxin. Allergy 
and Asthma Proceedings. 1999; 20(3): 141-146. PubMed PMID: 10389546. 
 
Griesbeck M, Ziegler S, Laffont S, Smith N, Chauveau L, Tomezsko P, Sharei A, Kourjian G, 
Porichis F, Hart M, Palmer CD, Sirignano M, Beisel C, Hildebrandt H, Cénac C, Villani AC, 
Diefenbach TJ, Le Gall S, Schwartz O, Herbeuval JP, Autran B, Guéry JC, Chang JJ, Altfeld 
M. Sex Differences in Plasmacytoid Dendritic Cell Levels of IRF5 Drive Higher IFN-α 
Production in Women. Journal of Immunology. 2015; 195(11): 5327-5336. Published 




Groom JR, Luster AD. CXCR3 ligands: redundant, collaborative and antagonistic 
functions. Immunology and Cell Biology. 2011; 89(2): 207-215. doi: 
10.1038/icb.2010.158. Published Online 2011 January 11. PubMed PMID: 21221121. 
Ibricevic A, Pekosz A, Walter MJ, Newby C, Battaile JT, Brown EG, Holtzman MJ, Brody 
SL. Influenza Virus Receptor Specificity and Cell tropism in Mouse and Human Airway 
Epithelial Cells. Journal of Virology. 2006; 80(15): 7469-7480. doi: 10.1128/JVI.02677-05. 
PubMed PMID: 16840327. 
 
Influenza (Seasonal). WHO factsheet. 2015. 
 
Iversen MB, Reinert LS, Bagdonaite I, Nandakumar R, Cheshenko N, Prabakaran T, 
Vakhrushev SY, Kryzowska M, Kratholm SK, Ruiz-Perez F, Petersen SV, Goriely S, Bibby 
BM, Eriksson K, Ruland J, Thomsen AR, Herold BC, Wandall HH, Frische S, Holm CK, 
Paludan SR. An innate antiviral pathway acting before interferons at epithelial surfaces. 
Nature Immunology. 2016; 17(2): 150-158. doi: 10.1038/ni.3319. Published Online 2015 
November 30. PubMed PMID: 26595890. 
 
 
Jagger BW, Wise HM, Kash JC, Walters KA, Wills NM, Xiao YL, Dunfree RL, Schwartzman 
LM, Ozinsky A, Bell GL, Dalton RM, Lo A, Efstathiou S, Atkins JF, Firth AE, Taubenberger 
JK, Digard P. An overlapping protein-coding region in influenza A virus segment 3 
modulates the host response. Science. 2012; 337(6091): 199-204. doi: 
10.1126/science.1222213. Published Online 2012 June 28. PubMed PMID: 22745253. 
 
Kash JC, Tumpey TM, Proll SC, Carter V, Perwitasari O, Thomas MJ, Basler CF, Palese P, 
Taubenberger JK, García-Sastre A, Swayne DE, Katze MG. Genomic analysis of increased 
host immune and cell death responses induced by 1918 influenza virus. Nature. 2006; 
443(7111): 578-581. Published Online 2006 September 27. PubMed PMID: 17006449.  
 
Klein SL, Jedlicka A, Pekosz A. The Xs and Y of immune responses to viral vaccines. The 
Lancet of Infectious Diseases. 2010; 10(5): 338-349. doi: 10.1016/S1473-3099(10)70049-
9. PubMed PMID: 20417416. 
 
Klein SL, Pekosz A, Passaretti C, Anker M, Olukoya P. Sex, Gender and Influenza. World 
Health Organization, Geneva. 2010; 1–58. 
 
Kohanski MA, Lane AP. Sinonasal epithelial cell response to Staphylococcus aureus 
burden in chronic rhinosinusitis. JAMA otolaryngology-- head & neck surgery. 
2015;141(4):341-9. Published Online 2015 January 23. doi: 10.1001/jamaoto.2014.3550. 




Koopman P, Gubbay J, Vivian N, Goodfellow P, Lovell-Badge R. Male Development of 
chromosomally female mice transgenic for Sry. Nature. 1991; 351(6322): 117-121. 
PubMed PMID: 2030730. 
 
Lagace-Wiens PRS, Rubinstein E, Gumel A. Influenza epidemiology-past, present, and 
future. Critical Care Medicine. 2010; 38(4): e1-e9. doi: 
10.1097/CCM.0b013e3181cbaf34. PubMed PMID: 20029350. 
 
Larcombe AN, Foong RE, Bozanich EM, Berry LJ, Garratt LW, Gualano RC, Jones JE, 
Dousha LF, Zosky GR, Sly PD. Sexual dimorphism in lung function responses to acute 
influenza A infection. Influenza and Other Respiratory Viruses. 2011; 5(5): 334-342. doi: 
10.1111/j.1750-2659.2011.00236.x. Published Online 2011 March 21. PubMed PMID: 
21668688. 
 
Lorenzo ME, Hodgson A, Robinson DP, Kaplan JB, Pekosz A, Klein SL. Antibody responses 
and cross protection against lethal influenza A viruses differ between the sexes in 
C57BL/6 mice. Vaccine. 2011; 29(49): 9246-9255. doi: 10.1016/j.vaccine.2011.09.110. 
Published Online 2011 October 6. PubMed PMID: 21983155.  
 
Mandell, Douglas, and Bennett’s Principles and Practices of Infectious Diseases, volume 
2. 2014.  Churchill Livingston Elsevier. Chapter: Viral Infections of Humans, pg. 455-478.  
 
McCown MF, Pekosz A. The influenza A virus M2 cytoplasmic tail is required for 
infectious virus production and efficient genome packaging. Journal of virology. 
2005;79(6):3595-605.Published Online 2005 February 26. doi: 79/6/3595 
[pii]10.1128/JVI.79.6.3595-3605.2005. PubMed PMID: 15731254; PMCID: 1075690. 
 
Meier A, Chang JJ, Chan ES, Pollard RB, Sidhu HK, Kulkarni S, Wen TF, Lindsay RJ, 
Orellana L, Mildvan D, Bazner S, Streeck H, Alter G, Lifson JD, Carrington M, Bosch RJ, 
Robbins GK, Altfeld M. Sex differences in the Toll-like receptor-mediated response of 
plasmacytoid dendritic cells to HIV-1. Nature Medicine. 2009; 15(8): 955-959. Published 
Online 2009 July 13. doi: 10.1038/nm.2004. PubMed PMID: 19597505. 
 
Mittelstrass K, Ried JS, Yu Z, Krumsiek J, Gieger C, Prehn C, Roemisch-Margl W, 
Polonikov A, Peters A, Theis FJ, Meitinger T, Kronenberg F, Weidinger S, Wichmann HE, 
Suhre K, Wang-Sattler R, Adamski J, Illig T. Discovery of sexual dimorphisms in metabolic 
and genetic biomarkers. PLoS Genetics. 2011; 7(8): e1002215. Published Online 2011 
August 11. doi: 10.1371/journal.pgen.1002215. PubMed PMID: 21852955. 
 
Muller L, Brighton LE, Carson JL, Fisher II WA, Jaspers I. Culturing of Human Nasal 
Epithelial Cells at the Air Liquid Interface. Journal of Visualized Experiments. 2013; (80): 





Muller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, Zinkernagel RM, Aguet M. Functional 
role of type I and type II interferons in antivirial defense. Science. 1994; 264(5167): 
1918-1921. PubMed PMID: 8009221. 
 
Nayak DP, Balogun RA, Yamada H, Zhou ZH, Barman S. Influenza virus morphogenesis 
and budding. Virus Research. 2009; 143(2): 147-61. doi: 10.1016/j.virusres.2009.05.010. 
Published online 2009 May 27. PubMed PMID: 19481124. 
 
Nemeroff ME, Barabino SM, Li Y, Keller W, Krug RM. Influenza virus NS1 protein 
interacts with the cellular 30 kDa subunit of CPSF and inhibits 3’end formation of cellular 
pre-mRNAs. Molecular Cell. 1998; 1(7): 991-1000. PubMed PMID: 9651582. 
Penaloza C, Estevez B, Orlanski S, Sikorska M, Walker R, Smith C, Smith B, Lockshin RA, 
Zakeri Z. Sex of the cell dictates its response: differential gene expression and sensitivity 
to cell death inducing stress in male and female cells. FASEB Journal. 2009; 23(6): 1869-




Peiris JS, Cheung CY, Leung CY, Nicholls JM. Innate immune responses to influenza A 
H5N1: friend or foe? Trends in Immunology. 2009; 30(12): 574-584. doi: 
10.1016/j.it.2009.09.004. Published Online 2009 October 26. PubMed PMID: 19864182. 
Practice Guidelines for LGB Clients: Definition of Terms. American Psychological 
Association. 2011.  
 
Pekosz A, Newby C, Bose PS, Lutz A. Sialic acid recognition is a key determinant of 
influenza A virus tropism in murine trachea epithelial cell cultures. Virology. 
2009;386(1):61-7. doi: 10.1016/j.virol.2009.01.005. Published Online 2009 February 7. 
PubMed PMID: 19195676; PMCID: Pmc4138309. 
 
Pollitzer E. Biology: Cell sex matters. Nature. 2013; 500(7460):23-24. doi: 
10.1038/500023a. PubMed PMID: 23903733. 
 
Rabinowitz P, Perdue M, Mumford E. Contact variables for exposure to avian influenza 
H5N1 virus at the human-animal interface. Zoonoses and Public Health. 2010; 57: 227-
238. doi: 10.1111/j.1863-2378.2008.01223.x. PubMed PMID: 19486500. 
 
Ramanathan M, Jr., Lane AP. A comparison of experimental methods in molecular 
chronic rhinosinusitis research. American journal of rhinology. 2007;21(3):373-7. 




Randall RE, Goodbourn S. Interferons and viruses: an interplay between induction, 
signaling, antiviral responses and virus countermeasures. The Journal of General 
Virology. 2008; 89(Pt1): 1-47. PubMed PMID: 18089727.  
 
Rapid Reference to Influenza. 2006. Elsevier Ltd.  Chapter 2, The Influenza Virus: 
Structure and Replication.  
 
Rettew JA, Huet-Hudson YM, Marriott I. Testosterone reduces macrophage expression 
in the mouse of toll-like receptor 4, a trigger for inflammation and innate immunity. 
Biology of Reproduction. 2008; 78(3): 432-437. Published Online 2007 November 14. 
PubMed PMID 18003947. 
 
Roberts R, Govender D. Gene of the month: KIT. Journal of Clinical Pathology. 2015; 
68(9): 671-674. Published Online 2015 July 1. doi: 10.1136/jclinpath-2015-
203207.PubMed PMID: 26135312. 
 
Robinson DP, Huber SA, Moussawi M, Roberts B, Teuscher C, Watkins R, Arnold AP, Klein 
SL. Sex chromosomes compelement contributes to sex differences in coxsackievirus B3 
but not influenza A virus pathogenesis. Biological Sex Differences. 2011; 2(8): doi: 
10.1186/2042-6410-2-8. PubMed PMID: 21806829. 
 
Robinson DP, Lorenzo ME, Jian W, Klein SL. Elevated 17-estradiol protects females 
from influenza A virus pathogenesis by suppressing inflammatory responses. PLoS 
Pathogens. 2011; 7(7): e1002149. doi: 10.1371/journal.ppat.1002149. Published Online 
2011 July 28. PubMed PMID: 21829352.  
 
Rouse BT, Sehrawat S. Immunity and immunopathology to viruses: what decides 
outcome? Nature Reviews-Immunology. 2010; 10(7): 514-526. doi: 10.1038/nri2802. 
Pubmed PMID: 20577268. 
 
Samji T. Influenza A: understanding the viral life cycle. Yale Journal of Biological 
Medicine. 2009; 82(4): 153-9. PubMed PMID: 20027280. 
 
Short KR, Kroeze EJ, Fouchier RA, Kuiken T. Pathogenesis of influenza-induced acture 
respiratory distress syndrome. The Lancet Infectious Diseases. 2014; 14(1): 57-69. doi: 
10.1016/S1473-3099(13)70286-X. Published online 2013 November 13. PubMed PMID: 
24239327.  
 
Short KR, Veldhuis Kroeze EJ, Reperant LA, Richard M, Kuiken T. Influenza virus and 
endothelial cells: a species specific relationship. Frontiers in Microbiology. 2014; 5: 653. 





Smith BK, Bonen A, Holloway GP. A dual mechanism of action for skeletal muscle 
FAT/CD36 during exercise. Exercise Sports Scientific Review. 2012; 40(4): 211-217. 
PMID:22653277. 
 
Sommereyns C, Paul S, Staeheli P, Michiels T. IFN-lambda (IFN-lambda) is expressed I a 
tissue-dependent fashio and primarily acts on epithelial cells in vivo. PLoS Pathogen. 
2008; 4(3): e1000017. doi: 10.1371/journal.ppat.1000017. PubMed PMID: 18369468. 
 
Soulat D, Burchstummer T, Westermayer S, Goncalves A, Bauch A, Stefanovic A, 
Hantschel O, Bennett KL, Decker T, Superti-Furga G. The DEAD-box helicase DDX3X is a 
critical component of the TANK-binding kinase 1-dependent innate immune response. 
The EMBO Journal. 2008; 27(15): 2135-2146. doi: 10.1038/emboj.2008.126. Published 
Online 2008 June 26. PubMed PMID: 18583960. 
 
Stark CR, Kerr IM, Williams BR, Silverman RH, Schreiber RD. How cells response to 
interferons. Annual Review of Biochemistry. 1998; 67: 227-264. PubMed PMID: 
9759489. 
 
Sterling TR, Vlahov D, Astemborski J, Hoover DR, Margolick JB, Quinn TC. Initial plamsa 
HIV-1 RNA levels and progression to AIDS in women and men. New England Journal of 
Medicine. 2001; 344(10): 720-725. PubMed PMID: 11236775. 
 
Wang SH, Yeh SH, Lin WH, Wang HY, Chen DS, Chen PJ. Identification of androgen 
response elements in the enhancer I of hepatitis B virus: a mechanism for sex disparity 
in chronic hepatitis B. Hepatology. 2009; 50(5): 1392-1402. doi: 10.1002/hep.23163. 
PMID: 19670412. 
 
Wang W, Shen T, Guerois R, Zhang F, Kuerban H, Lv Y, Gigant B, Knossow M, Wang C. 
New Insights into the Coupling between Microtuble Depolymerization and ATP 
Hydolysis by Kinesin-13 Protein Kif2C. Journal of Biological Chemistry. 2015; 290(3): 
18721-18723. Published Online 2015 June 8. doi: 10.1074/jbc.M115.646919. PMID: 
26055718. 
 
Wang X, Li M, Zheng H, Muster T, Palese P, Beg AA, Garcia-Sastre A. Influenza A virus 
NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon. 
Journal of Virology. 2000; 74(24): 11566-11573. PubMed PMID: 11090154. 
 
Wilson MA, Makova KD. Evolution and survival on eutherian sex chromosomes. PLoS 
Genetics. 2009; 5(7): e1000568. doi: 10.1371/journal.pgen.1000568. Published Online 
2009 July 17. PubMed PMID: 19609352. 
 
Yan Y, Tan KS, Li C, Tran T, Chao SS, Sugrue RJ, Shi L, Chow VT, Wang DY. Human nasal 
55 
 
epithelial cells derived from multiple subjects exhibit differential responses to H3N2 
influenza virus infection in vitro. Journal of Allergy and Clinical Immunology. 2016; 
S0091-6749(15)02992-9. doi: 10.1016/j.jaci.2015.11.016. PubMed PMID: 26806046. 
 
Yoshimura A, Kuroda K, Kawasaki K, Yamashina S, Maeda T, Ohnishi Shun-ichi. Infectious 
Cell Entry Mechanism of Influenza Virus. Journal of Virology. 1982; 43(1): 284-293. 
PubMed PMID: 7109028. 
 
Zhirnov OP, Konakova TE, Wolff T, Klenk HD. NS1 protein of influenza A virus down-





































534 Canton Court 
Baltimore, MD 21224 
(219) 713-0076 ·alisa.bochnowski@gmail.com 
 
PROFILE 
Master of Science candidate with training in infectious disease identification, pathogenesis, risk, 
and management. Public health researcher with a strong background in laboratory sciences, 
literature review and data abstraction, and quantitative risk assessment. 
 
EDUCATION 
Master of Science (ScM)                                                                    May 2016       Johns 
Hopkins Bloomberg School of Public Health, Baltimore, MD 
Thesis work: The Effect of Donor Sex on Influenza A Infection in Primary Human Nasal Epithelial 
Cell Cultures 
Bachelor of Science in Chemistry                                  December 2013    The 
George Washington University, Washington, DC 
 
PUBLIC HEALTH TRAINING 
Johns Hopkins Bloomberg School of Public Health, Baltimore, MD Aug. 2014 - Present 
Public Health Emergency Preparedness (Spring 2016) 
 Identified and described the main public health activities in preparing for and 
responding to public health emergencies 
 Identified and examined possible chemical, biological, radiological, nuclear, and 
explosive terrorist weapons 
 Described the role of public health agencies in emergencies, and interactions with public 
safety and other agencies 
Crisis and Response in Public Health Policy and Practice (Fall 2015) 
 Analyzed key elements of effective and ineffective day-to-day responses to crises at the 
local, state, national, and global levels 
 Examined how public health leaders can manage existing crises effectively to win 
significant, long-term policy advances 





PUBLIC HEALTH/RESEARCH EXPERIENCE 
 Analyzed data using appropriate statistical software such as SigmaPlot and Systat, 
presented data to a meeting of peers, presented data at a departmental meeting with 
senior faculty and investigators 
 Critically reviewed and analyzed published research, extracted chemical compound 
data, toxicity data, and other pertinent data from infectious disease journal articles for 
inclusion in the NIAID AIDS database 
 Developed a strategic plan for an organization, including a situational assessment and 
competitive analysis, identifying strategic options, and assessing and making 
appropriate plans and implementing the decided upon strategies 
 Described the chemical properties and biological processes which modulate the 
toxicokinetics of chemical agents of public health importance, determined the 
molecular, cellular, and pathophysiological responses resulting from exposure to 
chemical agents relevant to human health, used toxicology principles in conducting a 
risk assessment, identified the elements of a quantitative risk assessment by utilizing the 
framework developed by the National Research Council 
 Developed a thesis project looking at sex differences in pathogenesis of Influenza A 
infection in human nasal epithelial cells, including looking at viral replication kinetics, 
cytokine and chemokine production, and gene-level responses to infection 
 
WORK HISTORY 
Intern, Gryphon Scientific, LLC Takoma Park MD (Jan. 2014- June 2014 
Student Researcher, National Institute of Allergy and Infectious Disease, Bethesda, MD (May 
2013-July 2013)         
Research Assistant, Optimantra, Washington, DC (Dec. 2012-Sept 2013)    
                         
Student Researcher, National Aeronautics and Space Administration, Greenbelt, MD (June 
2012-Aug. 2012) 
Tutor, The George Washington Tutoring Initiative, Washington, DC (Sept.2012-May 2013) 
 
PUBLIC HEALTH EXPERIENCE 




 Worked with the Baltimore City Health Department to educate the community about 
HIV and Hepatitis C as well as provide testing and counseling services 
 Provided community outreach and support through auxiliary activities such as World 
AIDS day and Testing for Turkeys 
 
PROFESSIONAL DEVELOPMENT AND TECHNICAL SKILLS 
Technical proficiency in: Mass spectrometry, Flow cytometry, Western blotting, Cell culture, 
ELISA, MSD assay, microarray 
Computer Skills: Proficient in Word, Excel, Powerpoint, Access, Prism (graphical software), 
EndNote, FloJo, Ingenuity, Sigmaplot, Systat, research engines including Pubmed 
Training: Certified HIV and Hepatitis C counselor and tester 
 
 
